Lipocine Inc. (LPCN): Operating Income
-$10.37M
Year ended 2025-12-31
-$12.57M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$10.37M | n/m | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | -$1.16M | n/m | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | -$17.93M | n/m | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | -$12.12M | n/m | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | $3.15M | n/m | 2023-03-10, From 2021-01-01 |
| 2020-12-31 | -$18.00M | n/m | 2022-03-09, From 2020-01-01 |
| 2019-12-31 | -$12.90M | n/m | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | -$11.33M | n/m | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | -$21.22M | n/m | 2019-03-06, From 2017-01-01 |
| 2016-12-31 | -$19.19M | n/m | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | -$18.38M | n/m | 2018-03-12, From 2015-01-01 |
| 2014-12-31 | -$20.48M | n/m | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | -$10.68M | n/m | 2015-03-11, From 2013-01-01 |
| 2012-12-31 | $3.88M | n/a | 2014-03-31, From 2012-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Lipocine Inc. (LPCN) | 2025-12-31 | -$10.37M | n/m |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | -$177.93M | n/m |
| Bio Essence Corp (BIOE) | 2025-12-31 | $900.0K | n/m |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | -$4.97M | n/m |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | -$38.31M | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.64M | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$16.22M | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | -$3.08M | n/m |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$143.41M | n/m |
Compare LPCN, DNTH, BIOE, KRSA side by side · Screen every company in Pharmaceutical Preparations ↗